Suppr超能文献

在考虑患者入组不均匀、失访、不依从和分层的情况下,对生存分析的样本量和检验效能进行评估。

Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.

作者信息

Lachin J M, Foulkes M A

出版信息

Biometrics. 1986 Sep;42(3):507-19.

PMID:3567285
Abstract

When designing a clinical trial to test the equality of survival distributions for two treatment groups, the usual assumptions are exponential survival, uniform patient entry, full compliance, and censoring only administratively at the end of the trial. Various authors have presented methods for estimation of sample size or power under these assumptions, some of which allow for an R-year accrual period with T total years of study, T greater than R. The method of Lachin (1981, Controlled Clinical Trials 2, 93-113) is extended to allow for cases where patients enter the trial in a nonuniform manner over time, patients may exit from the trial due to loss to follow-up (other than administrative), other patients may continue follow-up although failing to comply with the treatment regimen, and a stratified analysis may be planned according to one or more prognostic covariates.

摘要

在设计一项临床试验以检验两个治疗组生存分布的相等性时,通常的假设是指数生存、患者均匀入组、完全依从以及仅在试验结束时进行管理性删失。许多作者已经提出了在这些假设下估计样本量或检验效能的方法,其中一些方法允许有一个R年的入组期,总研究时间为T年,T大于R。拉钦(1981年,《对照临床试验》2,93 - 113)的方法得到了扩展,以适用于患者随时间非均匀入组、患者可能因失访(而非管理性原因)退出试验、其他患者尽管未遵守治疗方案仍继续随访的情况,并且可以根据一个或多个预后协变量计划进行分层分析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验